Back to Research Home
HXLHexcel Corporation
Industrials · Major Chemicals · Mid
$79.62−2.03%
As of 23 Oct 2026Mkt cap $6.9B
Stage 13
AVOID
Fundamentals
35.5/75
Technical
4.6/15
Independent
40.1/90
GCAE viewFundamental /75 is below the Stage 13 acceptable-business floor
Price
- 1M
- −6.8%
- 3M
- −27.4%
- 6M
- −10.9%
- 1Y
- +24.9%
Financials & valuation
Cached filing evidence · as of 2026-10-21
Valuation
- P/E
- 35.7xHist median 53.1x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 30.4x
- FCF yield
- 3.3%
Quality
- ROIC
- 6.4%
- Operating margin
- 9.8%
- FCF margin
- 8.3%
- Current ratio
- 2.3x
Growth
- Revenue growth
- −0.5%Latest FY YoY
- Revenue CAGR
- +9.3%
- EPS CAGR
- +63.9%
- FCF CAGR
- +6.2%
Capital
- Share-count trend
- −3.3%3Y annualised
- Net debt
- $948M4.1x OCF
Annual trend
- CAGR 2021–2025
- +9.3%
- Latest · 2025
- $2B
- YoY
- −0.5%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- FUNDAMENTAL GATE FAIL
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
Fundamental /75 is below the Stage 13 acceptable-business floor
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2027-01-27
More details & evidence
Production decision
- Stage 13
- AVOID
- Technical state
- approaching-support
- Rotation
- headwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-21
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded